Prosecution Insights
Last updated: July 17, 2026
Application No. 17/814,798

MASK FOR NON-CONTACT RESPIRATORY MONITORING

Non-Final OA §101
Filed
Jul 25, 2022
Priority
Sep 15, 2021 — provisional 63/244,331
Examiner
ORTEGA, MARTIN NATHAN
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Covidien L.P.
OA Round
3 (Non-Final)
25%
Grant Probability
At Risk
3-4
OA Rounds
0m
Est. Remaining
57%
With Interview

Examiner Intelligence

Grants only 25% of cases
25%
Career Allowance Rate
20 granted / 79 resolved
-44.7% vs TC avg
Strong +32% interview lift
Without
With
+31.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 11m
Avg Prosecution
27 currently pending
Career history
116
Total Applications
across all art units

Statute-Specific Performance

§101
5.9%
-34.1% vs TC avg
§103
83.0%
+43.0% vs TC avg
§102
4.1%
-35.9% vs TC avg
§112
5.6%
-34.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 79 resolved cases

Office Action

§101
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 03/20/2026 has been entered. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-11, 13-18, and 20-22 are rejected under 35 U.S.C. 101 because the claim(s) as a whole, considering all claim elements both individually and in combination, do not amount to significantly more than an abstract idea. A streamlined analysis of claim 1 follows. STEP 1 Regarding claim 1, the claim recites a series of steps or acts, including producing a respiration image overtime. Thus, the claim is directed to a process, which is one of the statutory categories of invention. STEP 2A, PRONG ONE The claim is then analyzed to determine whether it is directed to any judicial exception. The step of producing a respiration image of the subject overtime sets forth a judicial exception. This step describes a concept performed in the human mind (including an observation, evaluation, judgment, opinion). Thus, the claim is drawn to a Mental Process, which is an Abstract Idea. STEP 2A, PRONG TWO Next, the claim as a whole is analyzed to determine whether the claim recites additional elements that integrate the judicial exception into a practical application. The claim fails to recite an additional element or a combination of additional elements to apply, rely on, or use the judicial exception in a manner that imposes a meaningful limitation on the judicial exception. The respiration image does not provide an improvement to the technological field, the method does not effect a particular treatment or effect a particular change based on the image, nor does the method use a particular machine to perform the Abstract Idea. STEP 2B Next, the claim as a whole is analyzed to determine whether any element, or combination of elements, is sufficient to ensure that the claim amounts to significantly more than the exception. Besides the Abstract Idea, the claim recites additional steps of determining depth data, analyzing the image, creating background image, analyzing each ROI for respiration, preparing masks, weighting the masks, combining the masks, and creating a visual respiration image . The above steps are well-understood, routine and conventional activity for those in the field of medical diagnostics. Further, the determining, analyzing, creating, weighting, and extracting steps are each recited at a high level of generality such that it amounts to insignificant presolution activity, e.g., mere data gathering step necessary to perform the Abstract Idea. When recited at this high level of generality, there is no meaningful limitation, such as a particular or unconventional step that distinguishes it from well-understood, routine, and conventional data gathering, analyzing data, and imaging producing activity engaged in by medical professionals prior to Applicant's invention. Furthermore, it is well established that the mere physical or tangible nature of additional elements such as the producing step does not automatically confer eligibility on a claim directed to an abstract idea (see, e.g., Alice Corp. v. CLS Bank Int'l, 134 S.Ct. 2347, 2358-59 (2014)). Consideration of the additional elements as a combination also adds no other meaningful limitations to the exception not already present when the elements are considered separately. Unlike the eligible claim in Diehr in which the elements limiting the exception are individually conventional, but taken together act in concert to improve a technical field, the claim here does not provide an improvement to the technical field. Even when viewed as a combination, the additional elements fail to transform the exception into a patent-eligible application of that exception. Thus, the claim as a whole does not amount to significantly more than the exception itself. The claim is therefore drawn to non-statutory subject matter. The same rationale applies to claim 13. The dependent claims also fail to add something more to the abstract independent claims as they generally recite method steps pertaining to data processing and the display of data. The producing step recited in the independent claims maintain a high level of generality even when considered in combination with the dependent claims. Examiner’s Note The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Suzuki et al. teaches the smoothed bone-image-like image f.sub.S(x,y) of the multi-resolution MTANN was subtracted from the corresponding chest radiograph g(x,y) with the mask image m(x,y) as follows: s(x,y)=g(x,y)-w.sub.S.times.f.sub.S(x,y).times.m(x,y), (7) where w.sub.S is a weighting parameter for determining the contrast of ribs. US 7545965 Rubin et al. combining the first lung tracking data and the second lung tracking data to create stage combination data may further include calculating a robustness weighting value for each frame of the temporally-filtered robustness set of sub-images and the lung surface mask set of sub-images from a robustness stage correlation magnitude and robustness predetermined threshold limits. US 20230165567 Schleyer et al. a phase weighted mask is created for each axial section, to identify voxels that are subject to a respiratory motion. Thus, all the phase weighted masks allow a further analysis to be performed only on the voxels in the volumes that are moving. US 20210106301 Charles et al. teaches creating lung masks from the .sup.1H MRI images, apply the created masks to the registered .sup.19F images, then extract summary parameters from the .sup.19F image data to assess ventilation defects. US 20130006094 Kadbi et al. teaches a medical system comprising a memory for storing machine-executable instructions. Execution of the instructions causes the processor to receive four-dimensional Dixon magnetic resonance image data. The four-dimensional Dixon magnetic resonance image data is T1 weighted. The four-dimensional Dixon magnetic resonance image data is synchronized to a respiratory signal. US 20220299587 Due to the 35 U.S.C. 101 rejection above, allowable subject matter cannot be determined and/or identified at this time. Response to Arguments Applicant's arguments filed 02/20/2026 have been fully considered but they are not fully persuasive. Applicant contends that the particular processing steps and display output show an improvement to the technology or technological field because they provide a practical solution for determining a respiratory rate of a patient using a non-contact monitoring system, on pages 9-10 of the Remarks. Examiner disagrees. First, respiratory rate is not claimed in any limitation. Second, even assuming arguendo, there is no practical application of the respiratory rate. Determining respiratory rate is pre-solution activity to a practical solution, e.g. providing therapy or surgery based on the determined respiratory rate. That is, the claims are required to provide more than just presolution activity to a practical application. This can be achieved by providing therapy or the like based on the presolution activity or using a particular machine to perform the Abstract Idea, e.g. the particulars of a depth camera. Applicant argues that there is no generic recitation of general computer components, but rather a special purpose medical apparatus that provides a technical solution to a technical problem to produce actionable medical output for treating a patient, on page 11 of the Remarks. Examiner disagrees. Examiner invites Applicant to point out where the particulars for the computer components are recited in the claims or specification. There is no recitation of any computer component in the independent claims. Moreover, the actionable output for treating a patient is not apparent based on the claims. By providing a treatment based on the output in the claims may help in overcoming the 35 U.S.C. 101 rejection. Applicant argues that the respiratory image produced in claim 1 provides an actionable output for medical caregivers to improve patient care, therefore integrates the judicial exception into a practical application, on page 11-12 of the Remarks. Examiner disagrees. Based on the plain language of the claims, there is no determination of irregular respiration parameters, if anything, the claims are merely directed to determining whether respiration is happening in general. However, this is different from any determination of abnormality that results in medical intervention. That is, there is no determination of any abnormalities or providing an output of such abnormalities to a third party for therapy. Applicant argues that amended claim 1 as a whole amounts to significantly more than any mental step because of the specific processing, extraction steps, and the display of an image, on page 13 of the Remarks. Examiner disagrees. The claims as written merely provide pre-solution data gathering (obtaining data from depth camera), using a computer to perform the abstract idea (producing the image), and insignificant extra-solution activity to the judicial exception (displaying the produced image). MPEP 2106.05(g); see, e.g., Alice Corp. v. CLS Bank Int'l, 134 S.Ct. 2347, 2358-59 (2014)). Applicant arguments related to 35 U.S.C. 103 and 112(b) rejections and in view of the amendments, overcome the previously stated rejection. As such, the rejections have been withdrawn. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MARTIN NATHAN ORTEGA whose telephone number is (571)270-7801. The examiner can normally be reached M-F 7:10 am - 5:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert (Tse) Chen can be reached at (571) 272-3672. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MARTIN NATHAN ORTEGA/ Examiner, Art Unit 3791 /TSE CHEN/Supervisory Patent Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Jul 25, 2022
Application Filed
Jun 13, 2025
Non-Final Rejection mailed — §101
Sep 11, 2025
Response Filed
Dec 23, 2025
Final Rejection mailed — §101
Feb 20, 2026
Response after Non-Final Action
Mar 20, 2026
Request for Continued Examination
Apr 13, 2026
Response after Non-Final Action
Jun 24, 2026
Non-Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678101
METHOD AND APPARATUS FOR DETERMINING THE OPERATIONAL STATE OF A CONTACT DEVICE
5y 0m to grant Granted Jul 14, 2026
Patent 12672785
Method and Apparatus for Obtaining Relevnt Characteristic Parmeters and Indexes of Tonoarteriogram (TAG) Signals
4y 8m to grant Granted Jul 07, 2026
Patent 12672798
DETECTION OF BIOMARKERS IN SWEAT
4y 9m to grant Granted Jul 07, 2026
Patent 12667433
Robotized Module for Guiding an Elongate Flexible Medical Device
9y 6m to grant Granted Jun 30, 2026
Patent 12653460
METHOD AND APPARATUS OF LOCATING TUMOR
5y 5m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
25%
Grant Probability
57%
With Interview (+31.8%)
3y 11m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 79 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month